Pretreatment with either drug led to altered goblet cell morphology and reduced secretion based on Muc2 staining (Supplementary Fig. 4a), which significantly reduced virus infection and shedding based on qRT-PCR (Fig. 3a, b) and ISH staining (Supplementary Fig. 4b). Here, MUC2 is linked to viral infectious disease.